DOI: 10.1148/radiol.253280 ISSN: 0033-8419
Comparison of Second-line Hepatic Arterial Infusion Chemotherapy and Tyrosine Kinase Inhibitors in Advanced Hepatocellular Carcinoma
Jae-Sung Yoo, Kwon Yong Tak, Hee Sun Cho, Ji Won Han, Jeong Won Jang, Jaejun Lee, Hyun Yang, Chang Wook Kim, Hae Lim Lee, Hee Yeon Kim, Suho Kim, Jung Suk Oh, Ho Jong Chun, Heechul Nam, Pil Soo SungIn patients with advanced hepatocellular carcinoma, after atezolizumab-bevacizumab failure, second-line hepatic arterial infusion chemotherapy yielded higher response rates and longer progression-free survival than tyrosine kinase inhibitors.